Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Aug;19(4):345-57.
doi: 10.1080/09540260701486563.

Very poor outcome schizophrenia: clinical and neuroimaging aspects

Affiliations
Review

Very poor outcome schizophrenia: clinical and neuroimaging aspects

Serge A Mitelman et al. Int Rev Psychiatry. 2007 Aug.

Abstract

In spite of significant advances in treatment of patients with schizophrenia and continued efforts towards their deinstitutionalization, a considerable group of patients remain chronically hospitalized or otherwise dependent on others for basic necessities of life. It has been proposed that these patients belong to a distinct etiopathological subgroup, termed Kraepelinian, whose course of illness may be progressive and resistant to treatment. Indeed, longitudinal studies appear to show that elderly Kraepelinian patients follow a course of rapid cognitive and functional deterioration, commensurate with a dementing process, and that their poor functional status is closely correlated with the cognitive deterioration. Recent neuroimaging studies described a pattern of posteriorization of grey and white matter deficits with poor outcome in schizophrenia, and produced a constellation of findings implicating primary processing of visual and auditory information as central to the impaired functional status in this patient group. These studies are summarized in detail in this review and future directions for neuroimaging assessment of very poor outcome patients with schizophrenia are suggested.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Temporal lobe volume loss and lateral ventricular enlargement in a schizophrenia patient with poor outcome (right) in comparison to a patient with good outcome (left).
Figure 2
Figure 2
Lower fractional anisotropy in the posterior callosal regions in a patient with poor outcome (right) in comparison to a patient with good outcome (left).

References

    1. Albus M, Hubmann W, Ehrenberg C, Forcht U, Mohr F, Sobizack N, et al. Neuropsychological impairment in first-episode and chronic schizophrenic patients. European Archives of Psychiatry Clinical Neurosciences. 1996;246:249–255. - PubMed
    1. Arnold SE, Lee VM, Gur RE, Trojanowski JQ. Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia. Proceedings of the National Academy of Sciences USA. 1991;88:10850–10854. - PMC - PubMed
    1. Arnold SE, Gur RE, Shapiro RM, Fisher KR, Moberg PJ, Gibney MR, et al. Prospective clinicopathologic studies of schizophrenia: Accrual and assessment of patients. American Journal of Psychiatry. 1995a;152:731–737. - PubMed
    1. Arnold SE, Franz BR, Trojanowski JQ, Moberg PJ, Gur RE. Glial fibrillary protein-immunoreactive astrocytosis in elderly patients with schizophrenia and dementia. Acta Neuropathologica. 1995b;91:269–277. - PubMed
    1. Arnold SE, Trojanowski JQ. Cognitive impairment in elderly schizophrenia: A dementia (still) lacking distinctive histopathology. Schizophrenia Bulletin. 1996;22:5–9. - PubMed

Publication types